Policy | August 24, 2023
First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
Subscribe To Our Newsletter & Stay Updated
